Skip to Content

Organovo Holdings Inc ONVO

Morningstar Rating
$1.00 −0.01 (0.70%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ONVO is trading at a 66% discount.
Price
$1.00
Fair Value
$7.77
Uncertainty
Extreme
1-Star Price
$49.47
5-Star Price
$9.35
Economic Moat
Msbx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ONVO is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1.01
Day Range
$1.001.03
52-Week Range
$0.893.00
Bid/Ask
$1.00 / $1.02
Market Cap
$10.07 Mil
Volume/Avg
33,950 / 205,656

Key Statistics

Price/Earnings (Normalized)
Price/Sales
38.62
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
24

Valuation

Metric
ONVO
Price/Earnings (Normalized)
Price/Book Value
1.69
Price/Sales
38.62
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
ONVO
Quick Ratio
3.13
Current Ratio
3.67
Interest Coverage
Quick Ratio
ONVO

Profitability

Metric
ONVO
Return on Assets (Normalized)
−110.86%
Return on Equity (Normalized)
−138.84%
Return on Invested Capital (Normalized)
−125.43%
Return on Assets
ONVO
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRQfkf$552.7 Bil
VRTX
Vertex Pharmaceuticals IncPpqwgf$110.2 Bil
REGN
Regeneron Pharmaceuticals IncCqqbwl$105.9 Bil
MRNA
Moderna IncBvg$37.9 Bil
ARGX
argenx SE ADRSyxfw$23.9 Bil
BNTX
BioNTech SE ADRMrlzn$22.2 Bil
ALNY
Alnylam Pharmaceuticals IncKfprlz$20.5 Bil
BMRN
Biomarin Pharmaceutical IncMbvvbk$16.9 Bil
RPRX
Royalty Pharma PLC Class AWkkbvlh$13.9 Bil
INCY
Incyte CorpLyqwql$13.7 Bil

Sponsor Center